Data updated: Mar 10, 2026
KABIVEN IN PLASTIC CONTAINER
AMINO ACIDS
Approved 2014-08-25
1
Indication
--
Phase 3 Trials
11
Years on Market
Details
- Status
- Prescription
- First Approved
- 2014-08-25
- Routes
- INTRAVENOUS
- Dosage Forms
- EMULSION
Companies
Active Ingredient: AMINO ACIDS , CALCIUM CHLORIDE , DEXTROSE , MAGNESIUM SULFATE , POTASSIUM CHLORIDE , SODIUM ACETATE , SODIUM GLYCEROPHOSPHATE , SOYBEAN OIL
Website: ↗
KABIVEN IN PLASTIC CONTAINER Approval History
Loading approval history...
What KABIVEN IN PLASTIC CONTAINER Treats
1 FDA approvalsOriginally approved for its first indication in 2014 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
KABIVEN IN PLASTIC CONTAINER FDA Label Details
ProKABIVEN IN PLASTIC CONTAINER Patents & Exclusivity
Latest Patent: May 2036
Patents (28 active)
US12390398
Expires May 3, 2036
+ 18 more patents
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.